DASVERE Trademark

Trademark Overview

On Monday, August 14, 2017, a trademark application was filed for DASVERE with the United States Patent and Trademark Office. The USPTO has given the DASVERE trademark a serial number of 87568685. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 22, 2021. This trademark is owned by Sunovion Pharmaceuticals Inc.. The DASVERE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder; pharmaceutical preparations for treating eating disorders
dasvere

General Information

Serial Number87568685
Word MarkDASVERE
Filing DateMonday, August 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 22, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder; pharmaceutical preparations for treating eating disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSunovion Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752
Party NameSunovion Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events

Event DateEvent Description
Monday, March 22, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 22, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020EXTENSION 5 GRANTED
Thursday, August 13, 2020EXTENSION 5 FILED
Tuesday, August 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 13, 2020TEAS EXTENSION RECEIVED
Friday, February 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 12, 2020EXTENSION 4 GRANTED
Wednesday, February 12, 2020EXTENSION 4 FILED
Wednesday, February 12, 2020TEAS EXTENSION RECEIVED
Tuesday, August 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 9, 2019EXTENSION 3 GRANTED
Friday, August 9, 2019EXTENSION 3 FILED
Friday, August 9, 2019TEAS EXTENSION RECEIVED
Wednesday, February 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 11, 2019EXTENSION 2 GRANTED
Monday, February 11, 2019EXTENSION 2 FILED
Monday, February 11, 2019TEAS EXTENSION RECEIVED
Wednesday, August 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 13, 2018EXTENSION 1 GRANTED
Monday, August 13, 2018EXTENSION 1 FILED
Monday, August 13, 2018TEAS EXTENSION RECEIVED
Tuesday, February 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2017ASSIGNED TO EXAMINER
Monday, August 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 17, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

dasvere pharmaceutical treating preparations disorders hyperactivity eating deficit disorder diseases central